BRCA1 and osteosarcoma: Because BRCA1/2 genes and several genes involved in HR repair were mutated in U2OS and K7M2 osteosarcoma cells, co-treatment of olaparib and irradiation may have increased the sensitivity to PARPi due to the "synthetic lethality effect" 26-28, 30.